This invention discloses the application of
inosine in the preparation of drugs that promote
testosterone secretion, belonging to the field of
biomedical technology. The effective
active ingredient of the above-mentioned drugs is only
inosine or its pharmaceutically acceptable salts. The dosage forms of the above-mentioned drugs are tablets, capsules, oral liquids, lozenges, granules, powders, pills, powders, ointments, elixirs, suspensions, powders, or injections. The routes of administration of the above-mentioned drugs are oral, transdermal, intramuscular, subcutaneous, or intravenous injection. Since
inosine exists under physiological conditions and can be metabolized by
intestinal microorganisms, reasonable supplementation of inosine is a
safer and more
effective method for restoring
testosterone.
Inosine helps maintain the
homeostasis of the intestinal
flora, and the experimental results of this invention further show that inosine can restore the damaged intestinal barrier, thus making it
safer. Moreover, this invention does not directly supplement exogenous
testosterone, therefore it is less likely to induce
spermatogenesis disorders or promote prostatic
hyperplasia.